CAMBRIDGE, Mass.–(BUSINESS WIRE)–Iterative Health, a pioneer in precision-medicine technologies for gastroenterology, announced today that it has partnered with Florida Research Institute (FRI), a leader in gastroenterology and hepatology research, to bring its AI-Recruitment (AIR) technology to the Florida region to standardize endoscopic scoring and give patients better access to more precise therapeutics by way of clinical trials. The implementation of AIR will aid in the recruitment of patients to clinical trials focused on advancing therapies for inflammatory bowel disease (IBD). The two organizations will help to democratize access to novel IBD therapeutics for all patients, regardless of where they receive care.
“We’re thrilled to partner with Iterative Health in order to advance patient care and increase access to clinical trials for patients in Florida,” said Dr. Souvik Sarkar, Principal Investigator and Medical Director at Florida Research Institute. “AIR will streamline the clinical trial identification process, increasing patients’ ability to participate in trials that may ultimately lead to better treatments and care. Both organizations are passionate about reducing healthcare disparities, and together, we look forward to helping democratize GI care.”